TLR4 and amyotrophic lateral sclerosis: In mouse models of ALS (hSOD1G93A), absence of TLR4, or its pharmacologic blockade with TAK-242, delays disease progression, attenuates glial reactivity in spinal cord, and reduces spinal motor neuron loss [190].